News | December 14, 2009

APBI Reduced Recurrence in Low-Risk DCIS Patients

External Beam APBI

December 14, 2009 - Patients with low-risk ductal carcinoma in situ (DCIS) who receive accelerated partial breast irradiation (APBI) after a lumpectomy had a lower rate of local recurrence, according to new research presented this week at the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium by an investigator at The Cancer Institute of New Jersey (CINJ).

In DCIS, the cancer cells are inside the milk ducts of the breast, but have not spread to surrounding breast tissue. A previous study (Intergroup Study E5194) by the Eastern Cooperative Oncology Group and the North Central Cancer Treatment Group withheld radiation therapy from a low-risk subset of patients with DCIS after removal of the cancer. At five years, the local recurrence rate for low- and intermediate-grade patients was 6.8 percent, and 13.7 percent for high-grade patients.

In study, conducted by Sharad Goyal, M.D., instructor of radiation oncology at UMDNJ-Robert Wood Johnson Medical School, and senior author Bruce G. Haffty, M.D., chair of radiation oncology at CINJ and professor and chair of the department of radiation oncology at UMDNJ-Robert Wood Johnson Medical School, researchers looked at 69 patients between 2002 and 2004, who met the enrollment criteria for the previous study.

Following lumpectomy, patients in the new study were offered APBI, which is a one-week course of treatment that targets the specific area of the breast cavity where the cancer was removed. Investigators found that compared to the previous study, where radiation therapy was withheld, APBI greatly reduced the rate of local recurrence for low-risk DCIS patients (zero percent compared to 6.8 percent for low- to intermediate-grade patients and 5.3 percent compared to 13.7 percent for high-grade patients). Considering the shortened course of radiation (one week of APBI versus the traditional seven or eight), Dr. Goyal noted such treatment not only lessens the chance of recurrence but also could have great benefit to a patient’s quality of life in not having to travel continuously to the treatment site.

CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Co-authors of the study include Frank Vicini, William Beaumont Hospital, Mich.; Peter D. Beitsch, Dallas Breast Center, Texas; Martin Keisch, Miami Brachytherapy Center, Fla.; and Maureen Lyden, M.D., Anderson Cancer Center, Texas.

For more information: www.cinj.org

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Overlay Init